PDS01ADC in Combination With Hepatic Artery Infusion Pump (HAIP) and Systemic Therapy for Subjects With Metastatic Colorectal Cancer, Intrahepatic Cholangiocarc

PDS01ADC in Combination With Hepatic Artery Infusion Pump (HAIP) and Systemic Therapy for Subjects With Metastatic Colorectal Cancer, Intrahepatic Cholangiocarcinoma, or Metastatic Adrenocortical Carcinoma is a phase 2, interventional study registered as NCT05286814 by National Cancer Institute (NCI), with a registry enrolment figure of 70 participants, started 2022-10-24 and due to reach its primary completion in 2027-12-31. Interventions recorded: Dexamethasone; PDS01ADC; Intera 3000 Hepatic Artery Infusion Pump (HAIP); Floxuridine. Conditions listed: Metastatic Colorectal Cancer (Mcrc); Intrahepatic Cholangiocarcinoma (Icc); Intrahepatic Bile Duct Cancer; Colorectal Neoplasms; Colorectal Cancer; Cholangiocarcinoma; Bile Duct Neoplasms; Bile Duct Cancer; Adrenocortical Carcinoma (ACC); Adrenal Cortical Carcinoma; Adrenal Gland Cancer; Adrenal Gland Neoplasms; Adrenal Cortex Neoplasms. Primary outcome: Determine overall response rates. Colorectal eligibility wording from the registry: "* Metastatic colorectal cancer (mCRC)". Sites: United States. No results are recorded here; the registry entry is the source.